ストックスクリーナーアプリを入手
13.97
1.31%
0.18
アフターアワーズ：
13.95
-0.02
-0.14%
前日終値:
$13.79
開ける：
$13.65
24時間の取引高:
560.62K
Relative Volume:
1.45
時価総額：
$1.32B
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+37.77%
1か月 パフォーマンス:
-11.69%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$13.45
$14.37
1週間の範囲:
$10.21
$14.37
52週間の値動き範囲:
$9.965
$19.45
Lumexa Imaging Holdings Inc Stock (LMRI) Company Profile
Compare LMRI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LMRI
Lumexa Imaging Holdings Inc
|
13.97 | 1.30B | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Lumexa Imaging Holdings Inc Stock (LMRI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2026-01-05 | 開始されました | Barclays | Overweight |
| 2026-01-05 | 開始されました | Deutsche Bank | Buy |
| 2026-01-05 | 開始されました | JP Morgan | Overweight |
| 2026-01-05 | 開始されました | Jefferies | Buy |
| 2026-01-05 | 開始されました | Leerink Partners | Outperform |
| 2026-01-05 | 開始されました | Raymond James | Outperform |
| 2026-01-05 | 開始されました | Wells Fargo | Overweight |
| 2026-01-05 | 開始されました | William Blair | Outperform |
すべてを表示
Lumexa Imaging Holdings Inc (LMRI) 最新ニュース
Wall Street Analysts Are Bullish on Top Technology Picks - The Globe and Mail
Lumexa Imaging (NASDAQ:LMRI) Rating Increased to Strong-Buy at Raymond James Financial - Defense World
LMRI Lumexa Imaging Holdings, Inc. Common Stock Strong Buy Raymond James Feb 2026 - Meyka
Lumexa Imaging (NASDAQ:LMRI) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
FinancialContentLumexa Imaging Holdings, Inc.Common Stock (Nasdaq:LMRI) Stock Quote - FinancialContent
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care - The Malaysian Reserve
Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Adv - GuruFocus
Lumexa Imaging’s Dr. Kemp elected to RSNA board By Investing.com - Investing.com Canada
Lumexa Imaging Holdings, Inc.’s Quiet Period Set To End on January 20th (NASDAQ:LMRI) - Defense World
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March - Investing.com Nigeria
Lumexa Imaging Holdings, Inc. Announces Resignation of Chief Legal Officer and Corporate Secretary Julie Szeker, Effective March 13, 2026 - marketscreener.com
Lumexa Imaging Holdings chief legal officer Julie Szeker to resign in March By Investing.com - Investing.com South Africa
Lumexa Imaging Announces Chief Legal Officer Resignation - TipRanks
Assessing Lumexa Imaging Holdings (LMRI) Valuation After Recent Share Price Pullback - Yahoo Finance
Lumexa Imaging Holdings Grants $450,000 Transition Payment and Bonus to Departing Chief Legal Officer - Longbridge
LMRI: Global radiopharma leader drives growth with late-stage oncology pipeline and strategic expansion - TradingView — Track All Markets
Lumexa Imaging: Resilient Demand With Compounding Scale Moat (NASDAQ:LMRI) - Seeking Alpha
Lumexa Imaging Holdings, Inc.Common Stock (NQ: LMRI - FinancialContent
Lumexa Imaging Achieves Record De Novo Expansion in 2025 - Sahm
Lumexa Imaging Holdings, Inc.: Revenue and Earnings Analysts Forecasts Revisions | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Target Price Consensus and Analysts Recommendations | LMRI | US5502491062 - MarketScreener
Lumexa Imaging Holdings, Inc.: Dividend historical data and projections - MarketScreener
Analysts Offer Insights on Technology Companies: Advanced Micro Devices (AMD) and Lumexa Imaging Holdings, Inc. (LMRI) - The Globe and Mail
Analysts Offer Insights on Technology Companies: Broadcom (AVGO), Lumexa Imaging Holdings, Inc. (LMRI) and Apple (AAPL) - The Globe and Mail
Lumexa Imaging Holdings: Leveraging Outpatient Growth and JV Model to Drive Premium-Valued Expansion and Deleveraging Upside - TipRanks
Lumexa Imaging Announces Participation in Upcoming January 2026 Investor Conference - BioSpace
Lumexa Imaging Announces Participation in Upcoming Investor Conf - GuruFocus
Lumexa Imaging Announces Participation in Upcoming Investor Conference - Finviz
Lumexa Imaging Holdings: Secular Tailwinds, High-Return Expansion, and Joint-Venture Model Support Buy Rating - TipRanks
Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO - One News Page
Deutsche Bank Initiates Lumexa Imaging at Buy With $22 Price Target - marketscreener.com
Deutsche Bank initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com Canada
JPMorgan Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Jefferies Initiates Lumexa Imaging at Buy With $23 Price Target - marketscreener.com
Barclays Initiates Lumexa Imaging at Overweight With $23 Price Target - marketscreener.com
Leerink Partners Initiates Lumexa Imaging at Outperform With $23 Price Target - marketscreener.com
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
LMRI Archives - 24/7 Wall St.
Wells Fargo initiates Lumexa Imaging stock with Overweight rating By Investing.com - Investing.com Canada
Lumexa Imaging stock initiated with Outperform rating by William Blair - Investing.com
Lumexa Imaging Holdings: Capitalizing on Outpatient Imaging Tailwinds with Sustainable Growth and Attractive Risk-Reward - TipRanks
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating By Investing.com - Investing.com Nigeria
JPMorgan initiates Lumexa Imaging stock with Overweight rating, $23 target By Investing.com - Investing.com Canada
Jefferies initiates coverage on Lumexa Imaging stock with Buy rating - Investing.com
Lumexa Imaging Holdings Inc (LMRI) 財務データ
Lumexa Imaging Holdings Inc (LMRI) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.45%
0.31%
大文字化:
|
ボリューム (24 時間):